Today’s guest is J&J’s Ester in t’Groen and we will discuss what’s next for J&J in hematology in 2026—including some exciting readouts.
The post Johnson & Johnson’s hematology portfolio: breakthroughs to watch appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.
Nigeria Arrests RaccoonO365 Phishing Developer Linked to Microsoft 365 Attacks
Authorities in Nigeria have announced the arrest of three “high-profile internet fraud suspects” who are alleged to have been involved in phishing attacks targeting major
